Angiopoietin-Like 3: From Discovery to Therapeutic Gene Editing

Hyperlipidemia is a major causal risk factor for atherosclerosis and coronary heart disease (CHD). Angiopoietin-like 3 (ANGPTL3) has emerged as a promising molecular target to reduce CHD risk due to its regulation of all 3 major lipid traits: low-density lipoprotein cholesterol, high-density lipopro...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiao, Musunuru, Kiran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
STATE-OF-THE-ART REVIEW
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834959/
https://www.ncbi.nlm.nih.gov/pubmed/31709322
http://dx.doi.org/10.1016/j.jacbts.2019.05.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834959/
https://www.ncbi.nlm.nih.gov/pubmed/31709322
http://dx.doi.org/10.1016/j.jacbts.2019.05.008

Ejemplares similares